Changes to FOA RFA-TR-17-001 "Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02)"

Notice Number: NOT- TR-17-015

Key Dates
Release Date:   April 7, 2017

Related Announcements
RFA-TR-17-001

Issued by
National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this notice is change the requirement for Key Personnel to be listed in the X02 applications for FOA RFA-TR-17-001 “Pre-application for the NIH-Industry Program "Discovering New Therapeutic Uses for Existing Molecules (X02)"

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Currently reads:

SF424(R&R) Senior/Key Person Profile
All instructions in the SF424 (R&R) Application Guide must be followed. 

Not Applicable

Modified to read:

SF424(R&R) Senior/Key Person Profile
All instructions in the SF424 (R&R) Application Guide must be followed. 

All other aspect of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:


Bobbie Ann Austin, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-435-0824
Email: NewTherapeuticUses@mail.nih.gov